XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows from Operating Activities    
Net income $ 121,922 $ 137,992
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 30,347 28,012
Stock option expense 12,345 10,113
Litigation settlements paid (9,440)  
Noncash long-term incentive compensation 3,402 3,527
Noncash directors' compensation 1,173 1,171
Provision for deferred income taxes 1,051 2,717
Amortization of debt issuance costs 153 153
Provision for bad debts 40 871
Unutilized CARES Act grant   39,236
Deferred payroll taxes   10,716
Changes in operating assets and liabilities:    
Decrease in accounts receivable 4,722 6,696
Increase in inventories (316) (5)
Decrease/(increase) in prepaid expenses 3,337 (33)
(Decrease)/increase in accounts payable and other current liabilities (10,815) 13,303
Change in current income taxes (26,242) 23,725
Net change in lease assets and liabilities (436) 1,287
Increase in other assets (10,088) (2,988)
Increase in other liabilities 10,088 1,383
Other sources/(uses) 796 (54)
Net cash provided by operating activities 132,039 277,822
Cash Flows from Investing Activities    
Capital expenditures (33,604) (32,251)
Business combinations   (3,600)
Other sources/(uses) 302 473
Net cash used by investing activities (33,302) (35,378)
Cash Flows from Financing Activities    
Purchases of treasury stock (166,649) (122,148)
Proceeds from exercise of stock options 16,186 19,440
Dividends paid (10,864) (10,238)
Capital stock surrendered to pay taxes on stock-based compensation (8,598) (14,845)
Payments on revolving line of credit   (264,900)
Proceeds from revolving line of credit   174,900
Change in cash overdrafts payable   (9,849)
Other sources/(uses) 633 (586)
Net cash used by financing activities (169,292) (228,226)
(Decrease)/Increase in Cash and Cash Equivalents (70,555) 14,218
Cash and cash equivalents at beginning of year 162,675 6,158
Cash and cash equivalents at end of period $ 92,120 $ 20,376